journal article·2010-08Open access

Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations

Maziar Shah Mohammadi, Ifty Ahmed, Benedetto Marelli, Christopher Rudd, Martin N. Bureau, Showan N. Nazhat

Acta Biomaterialia· Volume 6· Issue 8

Abstract

Phosphate-based glasses (PGs) and their composites are of interest as bone repair and tissue engineering scaffolds due to the totally degradable nature of the materials. This study has investigated the effect of Si and Fe on the properties of PG particulate-filled polycaprolactone (PCL) matrix composites. Two glass compositions were investigated (mol.%): 50P(2)O(5), 40CaO and 10SiO(2) or Fe(2)O(3) (Si(10) and Fe(10), respectively). All composites contained 40 vol.% particulate filler, either Si(10), Fe(10), or a blend (40Si(10)/0Fe(10), 30Si(10)/10Fe(10), 20Si(10)/20Fe(10), 10Si(10)/30Fe(10) or 0Si(10)/40Fe(10)). Ion release, weight loss and composite mechanical properties were characterised as a function of time in deionised water (DW) and phosphate-buffered saline (PBS), respectively. The potential for calcium phosphate deposition was assessed in simulated body fluid (SBF). Calcium and phosphate ion release in DW increased in tandem with the rate of composite weight loss, which increased with Si(10) content. A Si(10) content dependent rate of pH reduction was observed in DW. After 56 days the PG in the 40Si(10)/0Fe(10) composite was completely dissolved, whereas 67% of that in the 0Si(10)/40Fe(10) composite remained. The initial flexural strength of 40Si(10)/0Fe(10) composites was significantly lower when compared with the other materials. An increase in Si(10) content led to an increase in Young's modulus and a concomitant decrease in flexural strain. It was found that the PCL molecular weight (M(w)) decreased dramatically with increasing Si(10) content. FTIR analysis showed that Si incorporation into PG led to reaction with the PCL ester bonds, resulting in a reduction in PCL M(w) when processed at elevated temperatures. Changes in mechanical properties with time in PBS were glass blend dependent and a more rapid rate of reduction was observed in higher Si(10) content composites. After 28 days in SBF surface deposited brushite was formed in 20Si(10)/20Fe(10) PG containing composites. Thus, the properties of PCL-PG composites could be tailored by controlling the phosphate glass blend composition.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Chemical Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Bioresorbable and bioactive polymer/Bioglass® composites with tailored pore structure for tissue engineering applications10.1016/S0266-3538(03)00275-6 ↗
2. Biomedical applications of polymer composite materials: a review10.1016/S0266-3538(00)00241-4 ↗
3. In vitro evaluation of poly(epsilon-caprolactone–co-dl-lactide)/bioactive glass composites10.1016/S0142-9612(01)00345-3 ↗
4. Engineering new bone tissue in vitro on highly porous poly(α-hydroxy acids)/hydroxyapatite composite scaffolds10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W ↗
5. Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q ↗
6. Polylactic acid-phosphate glass composite foams as scaffolds for bone tissue engineering
7. Preliminary biocompatibility screening of several biodegradable phosphate fiber reinforced polymers10.1002/jab.770040102 ↗
8. In vitro behavior of a novel bioresorbable composite material based on PLA and a soluble CaP glass10.1016/j.actbio.2005.03.004 ↗
9. Mechanical and structural characterisation of completely degradable polylactic acid/calcium phosphate glass scaffold10.1016/j.biomaterials.2007.06.029 ↗
10. Dynamic mechanical characterization of biodegradable composites of hydroxyapatite and polylactides10.1002/jbm.1026 ↗
11. Effect of filler content on mechanical and dynamic mechanical properties of particulate biphasic calcium phosphate polylactide composites10.1016/S0142-9612(01)00283-6 ↗
12. Characterization of silane-treated hydroxyapatite powders for use as filler in biodegradable composites10.1002/(SICI)1097-4636(199602)30:2<231::AID-JBM13>3.0.CO;2-P ↗
13. Biodegradation behavior of various calcium-phosphate materials in bone tissue10.1002/jbm.820170505 ↗
14. Phosphate based glasses for biomedical applications10.1039/b307119g ↗
15. Bioactive functional materials: a perspective on phosphate-based glasses10.1039/B810675D ↗
16. Investigation of silica–iron–phosphate glasses for tissue engineering10.1007/s10856-006-0183-x ↗
17. Effect of composition on the release kinetics of phosphate controlled release glasses in aqueous medium10.1016/j.jconrel.2003.12.030 ↗
18. Development of soluble glasses for biomedical use. Part 1: in vitro solubility measurement10.1023/A:1008949527695 ↗
19. Phosphate glass dissolution in aqueous solutions10.1016/0022-3093(84)90184-4 ↗
20. Physical and biocompatibility studies of novel titanium dioxide doped phosphate-based glasses for bone tissue engineering applications10.1007/s10856-007-3079-5 ↗
21. Comparison of phosphate-based glasses in the range 50P2O5–(50−x)CaO–xNa2O prepared using different precursors
22. Phosphate glasses for tissue engineering: Part 1. Processing and characterization of a ternary-based P2O5–CaO–Na2O glass system10.1016/S0142-9612(03)00546-5 ↗
23. Phosphate glasses for tissue engineering: Part 2. Processing and characterization of a ternary-based P2O5–CaO–Na2O glass fibre system10.1016/S0142-9612(03)00547-7 ↗
24. Synthesis, degradation, and in vitro cell response of sodium phosphate glasses for craniofacial bone repair10.1002/jbm.10020 ↗
25. Long-term craniofacial osteoblast culture on a sodium phosphate and a calcium/sodium phosphate glass10.1002/jbm.a.10574 ↗
26. Development of soluble glass for biomedical use. Part 2: the biological response of human osteoblast cell lines to phosphate-based soluble glasses10.1023/A:1008901612674 ↗
27. Processing, characterization and biocompatibility of iron–phosphate glass fibres for tissue engineering10.1016/j.biomaterials.2003.10.013 ↗
28. Effect of iron on the surface, degradation and ion release properties of phosphate-based glass fibres10.1016/j.actbio.2005.05.001 ↗
29. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study10.1016/0142-9612(91)90037-B ↗
30. Premature degradation of poly(α-hydroxyesters) during thermal processing of Bioglass® containing composites10.1016/j.actbio.2009.08.020 ↗
31. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
32. Quantification of anion and cation release from a range of ternary phosphate-based glasses with fixed 45mol.% P2O510.1177/0885328205049396 ↗
33. Effect of ternary phosphate based glass compositions on osteoblast and osteoblast-like proliferation, differentiation and death in vitro10.1016/j.actbio.2006.11.008 ↗
34. Weight loss, ion release and initial mechanical properties of a binary calcium phosphate glass fibre/PCL composite10.1016/j.actbio.2008.03.018 ↗
35. Porogen-based solid freeform fabrication of polycaprolactone – calcium phosphate scaffolds for tissue engineering10.1016/j.biomaterials.2006.03.049 ↗
36. Correlation of cancellous bone microarchitectural parameters from microCT to CT number and bone mechanical properties10.1016/j.msec.2006.05.003 ↗
37. Flexural and creep properties of human jaw compact bone for FEA studies10.1080/10255840310001637257 ↗
38. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part I: initial mechanical properties and bioactivity10.1016/j.actbio.2004.11.002 ↗
39. In vitro and in vivo behaviour of self-reinforced bioabsorbable polymer and self-reinforced bioabsorbable polymer/bioactive glass composites10.1002/jbm.a.30043 ↗
40. Williams · 1989
41. The role of brushite and octacalcium phosphate in apatite formation10.1177/10454411920030010601 ↗
42. In vitro bioactivity and gene expression by cells cultured on titanium dioxide doped phosphate-based glasses10.1016/j.biomaterials.2007.03.018 ↗
43. Silicon-substituted calcium phosphates – a critical view10.1016/j.biomaterials.2009.08.007 ↗